Galmed Pharmaceuticals GLMD
NASDAQ GLMD
$4.44 -0.12 (-2.63%)
As of: Aug 21, 2026 · 10:30 AM EDT

Galmed Pharmaceuticals (GLMD) Net Margin (2016 - 2018)

Galmed Pharmaceuticals (GLMD) posted quarterly Net Margin of 53.93% for Q3 2018, down 97207.0% year-over-year from N/an in Q3 2017, and up 2180.29% quarter-over-quarter from 2.59% in Q2 2018.

Galmed Pharmaceuticals (GLMD) Net Margin (2016 - 2018) Analysis & Trends

Galmed Pharmaceuticals' Net Margin history runs 3 years deep, the most recent figure standing at 53.93% for Q3 2018.

  • In Q3 2018, Net Margin fell 97207.0% year-over-year to 53.93%; the TTM figure through Jun 2019 stood at 252.15% (down 34389.0% YoY), while the FY2018 annual figure was 476.25%, down 38522.0% from the prior year.
  • Net Margin for Q3 2018 stood at 53.93%, up from 2.59% in the prior quarter.
  • The five-year high for Net Margin was 1876.68% in Q3 2016, with the low at 2.59% in Q2 2018.
  • The 3-year median for Net Margin is 1026.01% (2017), against an average of 915.36%.
  • The sharpest annual moves came in 2017 and 2018: Net Margin plunged 43139 bps in 2017, then plunged 117425 bps in 2018.
  • Galmed Pharmaceuticals' Net Margin stood at 1761.31% in 2016, then slipped by 24 bps to 1329.93% in 2017, then tumbled by 96 bps to 53.93% in 2018.
  • Business Quant data shows GLMD's Net Margin at 53.93% in Q3 2018, 2.59% in Q2 2018, and 10.82% in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 140.29 Bn 132.43 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 86.58 Bn 78.58 Bn 3.93 Bn 30.23%
3 Argenx Se 65.26 Bn 60.08 Bn 1.37 Bn 31.16%
4 Moderna 61.87 Bn 56.73 Bn 52.00 Mn -539.31%
5 BeOne Medicines 42.18 Bn 37.08 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 31.51 Bn 28.20 Bn 992.69 Mn 12.74%
7 BioNTech SE 28.90 Bn 10.51 Bn 668.28 Mn -16.51%
8 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -3.12%
9 Royalty Pharma 27.24 Bn 26.41 Bn - 12.09%
10 Galmed Pharmaceuticals 2.39 Mn -9.49 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2018 53.93%
Jun 30, 2018 -2.59%
Mar 31, 2018 10.82%
Dec 31, 2017 1,329.93%
Sep 30, 2017 1,026.01%
Jun 30, 2017 997.04%
Mar 31, 2017 1,185.07%
Dec 31, 2016 1,761.31%
Sep 30, 2016 1,876.68%